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There is ample evidence that dementia changes the processing of pain. However, it is not known whether this change in pain
processing is related to the general decline in cognitive functioning or whether it may be related to specific domains of cognitive
functioning.With the present studywe tried to answer this question.We assessed different cognitive domains (orientation,memory,
abstract thinking/executive function, aphasia and apraxia, and information processing speed) in 70 older patients with cognitive
impairment (mild cognitive impairment up to moderate degrees of dementia). Pain responsiveness was assessed by measuring the
nociceptive flexion reflex (NFR) threshold and facial responses to noxious electrical stimulation. Using regression analyses, we
assessed which domain of cognitive functioning best predicted variance in pain responsiveness. Variance in pain responsiveness
(NFR and facial expressions) was best explained by those items assessing executive functioning even when controlling for overall
cognitive performance and memory functioning. The close association between executive functioning and pain responsiveness
suggests that dementia-related neurodegeneration in prefrontal areas might result not only in reduced executive functioning
but also in a loss of pain inhibitory potency, rendering the patient more vulnerable to pain. Our findings also suggest that pain
assessment in dementia should be regularly completed by tests of cognitive functions.
1. Introduction
Prevalence rates for both dementia and pain are increasing
with age. Given the demographic changes in the coming
decades and the increasingly aging population there will be
a substantial growth in the number of individuals who will
be suffering from pain as well as from dementia [1]. When
an individual is suffering from both pain and dementia, it
is likely that these two conditions do not only cooccur but
also will interact with each other, with dementia changing the
processing of pain [2].
When trying to explain this interaction from a neuro-
biological perspective one could argue that there is a large
overlap in brain areas involved in pain processing and in
certain cognitive processes and that several of these areas
are affected by dementia-related neurodegeneration [3]. For
example, Alzheimer’s disease seems to mostly affect the
medial pain system, which is functionally responsible for
the affective-motivational dimension of pain processing, with
a focus on disruption in medial-temporal cortex areas [3].
This disruption in medial-temporal cortex areas could affect
pain processing [3] as well as memory functioning [4], with
both pain and memory functions possibly showing a parallel
decline in the course of dementia. However, there is also
ample evidence that prefrontal cortex areas deteriorate in the
course of dementia.The prefrontal cortex is involved not only
in descending pain inhibitory systems [5, 6] but also in
executive functioning [7]. Thus, functional disruption of
Hindawi Publishing Corporation
Behavioural Neurology
Volume 2015, Article ID 878157, 7 pages
http://dx.doi.org/10.1155/2015/878157
2 Behavioural Neurology
prefrontal areas might lead to a parallel worsening of pain
modulation and executive functions in the course of demen-
tia. While these neurobiological arguments alone might
appear speculative, an interaction between pain and cogni-
tion can be corroborated from a neuropsychological perspec-
tive. Memory for pain can help avoid future contact with
noxious stimuli or help successfully cope with pain, based
on previous experience. However, it is also conceivable that
action preparation and monitoring (precisely adjusted to the
actual situation) are necessary to lower the noxious risk and to
promote protective as well as coping behavior. Such planning
of action is part of what is called “executive functions.”
So, which cognitive domain is most closely linked to pre-
viously described [8, 9] changes in pain responses in patients
with dementia-related cognitive decline?Doesmemory func-
tioning or executive functioning or maybe even other types
of cognitive functioning explain dementia-related changes in
pain processing? To assess the relative contribution of differ-
ent cognitive functions to the prediction of pain processing in
patients with dementia-related cognitive decline, we studied
patients with manifest (mainly Alzheimer’s disease or mixed
forms of dementia) and potentially early forms (MCI) of
dementia. For inclusion, patients had to show impairments
in cognitive functioning with a preponderant decline in
memory. To assess the general cognitive status as well as
different cognitive domains at once, we used a comprehen-
sive but not too demanding cognitive test battery called
Structured Interview for the Diagnosis of Dementia of the
Alzheimer Type, Multi-infarct Dementia and Dementia of
other Etiology according toDSM-III-R, DSM-IV, and ICD-10
(SIDAM) [10]. The advantage of the SIDAM compared to the
Mini Mental State Examination (MMSE) [11] is the inclusion
of further items, which improves the resolution and distri-
bution of the performance parameters. Cognitive functions
included are “orientation,” “aphasia,” “apraxia,” “memory,”
and “intellectual abilities/executive function,” with latter two
functions being of special interest for the present study. We
also used a version of the Trail Making Test A (Zahlen-
Verbindungs-Test-G [12]) to assess “information processing
speed.”
The two questions to be answered were as follows. (i)
Which cognitive domain ismost predictive of pain processing
in patients with dementia-related cognitive decline? (ii)
Does this most predictive cognitive domain add additional
explained variance beyond that already explained by the
general cognitive status (MMSE) of the patient?
2. Materials and Methods
2.1. Participants. Seventy participants over the age of 65
(mean age: 75.6 ± 7.0 years; C: 40, D: 30) with different
degrees of dementia-related cognitive decline were included
in the study. Participantswere recruited amongst students of a
local adult education center (Volkshochschule) (mostly those
with mild cognitive impairments) and amongst inpatients
from the Department of Neurology and the Department of
Psychiatry and Psychotherapy of the University of Marburg
(mostly those participants at slight and moderate stages of
dementia). None had taken any analgesic medication for at
least 24 hours prior to the test session. Participants with any
condition other than cognitive impairment that could affect
pain perception and pain report such as diabetes, hyperten-
sion, peripheral and central neuropathy, and neurological
and psychiatric disorders were excluded from the study.
Prior to the experiment, a thorough neurological examina-
tion (including examination of the sensory system, motor
functioning (e.g., strength, gait, and deep tendon reflexes),
autonomic testing, and sural neurography) was conducted
in order to identify persons who met the exclusion criteria.
We only included individuals with either dementia or mild
cognitive impairment (MCI). MCI was diagnosed according
to the criteria of Petersen et al. [13]. Based on these criteria,
35 elderly individuals were categorized as individuals with
MCI (mean age: 75.4; mean MMSE: 25.9). Furthermore, 35
elderly individuals were categorized as patients with putative
dementia (mean age: 75.7; mean MMSE: 16.4) and were
examined by a neurologist or psychiatrist and diagnosed
according to the criteria specified by the ICD-10, NINCDS-
ADRDA [14], and NINDS-AIREN [15]. According to these
diagnostic guidelines, analyses of cerebrospinal fluid, blood
chemistry analysis, EEG, CT, or MRT and ECG analyses
were conducted besides clinical assessment. Twenty-three
patients met the NINCDS-ADRDA criteria for the clinical
diagnosis of probableAlzheimer’s disease orMixedDementia
and 12 patientsmet theNINDS-AIRENcriteria for the clinical
diagnosis of probable Vascular Dementia.
The study protocol was approved by the ethics committee
of the medical faculty of the University of Marburg. We took
care that only patients with dementia who still had legal
capacity were included in the study. After being informed in a
slow and simple fashion, which was adjusted to the individual
intellectual capacities, subjects gave written informed con-
sent. We also provided instructions during testing as simple
as possible and monitored the patients continuously for any
signs of undue discomfort (verbally or nonverbally), in which
case we stopped testing immediately.
2.2. Materials and Procedure. All testing was conducted
during the hours of 3.00 p.m.–6.30 p.m. and it lasted for
approximately 2 hours. Within these 2 hours, (i) a neuropsy-
chological examination lasting approximately 30minutes and
(ii) pain responses to electrical stimulation (30min) were
assessed. We also conducted a neurological examination (as
mentioned in the subject description) and assessed facial
responses to pressure stimuli (the results have been reported
elsewhere [8]). In order to help building up a nonthreatening
atmosphere for the subjects, we decided to always start with
pressure stimulation, since this procedure (for a detailed
description, see Kunz et al. [8]) was much less likely to elicit
anxiety or threat compared to electrical stimulation.
2.2.1. Neuropsychological Examination. We used the Struc-
tured Interview for the Diagnosis of Dementia of the
Alzheimer Type, Multi-infarct Dementia and Dementia of
other Etiology according toDSM-III-R, DSM-IV, and ICD-10
(SIDAM) [10] as well as the Zahlen-Verbindungs-Test (ZVT)
[12], which is similar to the Trail Making Test (version A)
to assess different domains of cognitive functioning. The
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SIDAM is amixed semistructured and structured instrument
which has been developed for diagnosing mild cognitive
impairment (MCI) and dementia. The cognitive section of
the SIDAM consists of 55 questions and allows calculating
subscores for the domains “orientation” (orientation for time
and place), “memory” (immediate recall and short-term and
long-term memory), “intellectual abilities/executive func-
tion” (abstract thinking and making plausibility judgments),
and “aphasia and apraxia” (naming objects and performing
according to instructions). The SIDAM also includes the
Mini Mental State Examination. With the ZVT we assessed
“information processing speed”.
2.2.2. Pain Responsiveness. Given that we previously found
that dementia was associated with changes in the nociceptive
flexion reflex (NFR) and in facial responses [9] we focused
on these two types of responses in the present study, although
we also assessed self-report ratings and autonomic responses
(see Kunz et al. [9] for more details).
Assessment of the Nociceptive Flexion Reflex (NFR). Electrical
stimulation and the NFR assessment (EMG recording) were
performed using a standard electrodiagnostic device (Viking
IV D, VIASYS Healthcare) with modified software. During
electrical stimulation, the subjects were seated upright in a
comfortable armchair with knees flexed at 130∘. The stimu-
lating electrode (bar electrode) was attached on the left calf
over the pathway of the sural nerve (sural neurography was
performed during the neurological examination preceding
the testing in order to exclude patients with sensory polyneu-
ropathy and in order to localize the sural nerve for NFR
stimulation). This individualized procedure, in contrast to
standardized retromalleolar stimulation in previous studies
[16], allows exact stimulation of the sural nerve as determined
during prior sural neurography. For recording, the differen-
tial surface electrode was attached ipsilaterally over the short
head of the biceps femorismusclewith the reference electrode
fixed near the tendon of the biceps femorismuscle at the head
of the fibula bone. We inspected, cleaned, and abraded skin
before to avoid electrode contact with skin abnormalities and
to keep the impedance at the lowest level possible.
A time window of 80–150ms was selected for the onset
of the reflex in order to exclude early RII responses and
voluntary limb movements according to the results of pre-
vious studies [17]. Furthermore, amplitude of at least 40 𝜇V
within 100ms after the reflex onset was required to reliably
distinguish reflex responses from baseline fluctuations. A
train of five impulses with 1ms duration at a frequency of
250Hz was used for stimulation. Between each stimulus
a variable interval from 20 to 30 seconds was used in
order to avoid habituation. The NFR threshold was assessed
using the up-down staircase method. Stimulation intensity
was increased in 3mA increments until the flexion reflex
RIII component was detected the first time or a maximum
stimulus intensity of 40mA was reached. Next, we lowered
stimulus intensity in 2mA steps until the reflex disappeared.
After that, steps of 1mA were used and the procedure was
repeated until the reflex appeared and subsided two more
times. Mean values of three peaks (current intensity that just
Table 1: Facial Action Units (AUs) with a critical frequency of
occurrence of more than 5% in supra-NFR threshold trials. Effect
sizes for frequency differences between “below threshold” and
“suprathreshold” trials are given.
Action Unit Description Frequency of occurrence
Percenta Effect size (Cohen’s 𝑑)
AU4 Brow lower 32.0 d = 1.05
AU6/7 Orbit tightening 78.7 d = 1.33
AU9/10 Levator contraction 23.7 d = 1.51
AU14 Dimpler 12.6 𝑑 = 0.42
AU17 Chin raise 14.0 d = 0.65
AU18 Lip pucker 11.3 𝑑 = 0.37
AU25/26/27 Mouth opening 62.8 d = 0.75
AU45 Blink 168.6 𝑑 = 0.19
Medium and strong effect sizes (𝑑 ≥ 0.5) are marked in bold.
aPercent denotes the percentage of occurrence in the entire suprathreshold
segments.
elicited a reflex) and three troughs (current intensity that just
no longer elicited a reflex) determined the reflex threshold.
Facial Responses. After the NFR threshold was assessed,
facial responses to 10 electrical stimuli with an intensity of
5mA above the individual NFR threshold were assessed. We
used suprathreshold intensities to ensure noxious stimulation
levels. Facial responses were assessed and analyzed according
to procedures described in detail previously [8, 9]. In short,
the face of the subject was videotaped throughout the entire
session and facial responses were later analyzed using the
Facial Action Coding System (FACS) [18].The FACS is a fine-
grained anatomically based system which is considered the
gold standard when decoding facial expressions, including
the facial expression of pain. A certified FACS coder iden-
tified the frequency and the intensity (5-point scale) of the
different Action Units. A software designed for the analy-
sis of observational data (the Observer Video-Pro; Noldus
Information Technology) was used to segment the videos
and to enter the FACS codes into a time-related database.
Time segments of 5 seconds after stimulus onset were
selected for scoring. For purpose of necessary data reduction,
we combined those AUs that represent facial movements
of the same muscle as has been done in preceding studies
without any loss of information [19–22].
To select those AUs that appeared to be pain-relevant in
the present experimental context and to summarize these
facial responses to composite scores, several steps were
necessary: (1) AUs had to occur in more than 5% of the
suprathreshold trials and (2) AUs had to be more frequent
during suprathreshold trials than during those trials below
theNFR threshold (those were taken from theNFR threshold
assessment) (effect size 𝑑 ≥ 0.5; these AUs are in italic font in
Table 1). Following this, mean AU frequency and mean AU
intensity values of the selected AUs were combined (product
terms) to form a composite score of pain-relevant facial
responses [9].Due to the fact that the composite scorewas not
distributed normally, scores were square root transformed.
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Intellectual abilities/executive function 3.3 1.7
Aphasia and apraxia 7.6 2.0
ZVT Information processing speed 84.1 54.7
SIDAM MMSE 21.2 6.2
Pain responsiveness NFR threshold (in mA) 16.4 9.0
Facial response (FACS composite score, sqrt.) 2.6 1.7
2.3. Statistical Analysis. In order to find out which domain
of cognitive functioning is most closely related to pain
responsiveness in individuals with dementia-related cogni-
tive decline, linear regression analyses were computed.
Step 1 (forward selection). The aim of Step 1 was to select
out of the different domains of cognitive functioning those
domains that contribute most to the prediction of variances
in pain responsiveness. Thus, multiple regression analyses
with forward selection were conducted separately for 2
criterion measures (NFR threshold and facial responses to
pain). As predictors we entered the SIDAM subscores for
the domains “orientation,” “memory,” “intellectual abili-
ties/executive function,” and “aphasia and apraxia.” In addi-
tion “information processing speed” (based on the ZVT) was
also entered.
Step 2a (predictive power compared to MMSE). The aim of
Step 2a was to evaluate whether those domains that proved
to be most predictive in Step 1 are indeed significantly better
predictors of pain responsiveness than a general indicator
of cognitive functioning. Therefore, we conducted blockwise
multiple regression analyses. We entered the MMSE score
into the first block of the regression analyses. In the second
block, we entered the “best predictors of Step 1.” Regression
analyseswere again conducted separately for the two criterion
measures.
Step 2b (predictive power compared to memory functioning).
Impairment in memory functioning is the most prevalent
cognitive impairment in individuals withMCI and dementia.
In case the best predictors from Step 1 do not include the
domain “memory,” the aimof Step 2bwas to evaluatewhether
those domains that proved to be most predictive in Step 1
are indeed significantly better predictors of variances in pain
responsiveness than the domain “memory.” Therefore, we
conducted blockwise multiple regression analyses, entering
“memory” performance into the first block and the “best
predictors of Step 1” into the second block of the regression
analyses. Regression analyses were again conducted sepa-
rately for the two criterion measures.
For description of simple relationships between the
predictor variables, Pearson’s correlation coefficients were
computed. Findings were always considered to be statistically
significant at 𝛼 < 0.05. SPSS 23 was used for all analyses.
3. Results
Table 2 gives an overview of the cognitive performance
within the different cognitive domains assessed in the present
sample. As can be seen, the average score of the MMSE
was 21, suggestingmild dementia-related impairment overall.
We also computed intercorrelations between the different
domains of cognitive functioning. As expected, the different
domains of cognitive functioning were all highly intercor-
related, with correlation coefficients ranging between 𝑟-
values of .563 to values of .739. The descriptive data of pain
responsiveness are also given in Table 2.
3.1. Which Domain of Cognitive Functioning Best Predicts
Variance in Pain Responsiveness?
Step 1 (forward selection).Both linear regression analyses con-
ducted showed that based on the forward selection procedure
only the cognitive domain “intellectual abilities/executive
function” remained a significant predictor in the model,
whereas all other domains were excluded (see Table 3). The
domain “intellectual abilities/executive function” explained
about 16% of the variance in pain responsiveness.
Step 2 (predictive power of the domain “intellectual abil-
ities/executive function” compared to (a) MMSE and (b)
memory functioning). Using blockwise regression analyses
entering (a) MMSE scores in the first block of the regression
model, we found a significant increase in explained variance
after entering “intellectual abilities/executive function” in the
second block. This was true for both types of pain responses
(NFR thresholds and facial responses). As can be seen
in Table 4, “intellectual abilities/executive function” added
approximately 5–8% of explained variance to the explanatory
power of the MMSE score. Thus, “intellectual abilities/
executive function” helps explain variances in pain responses
even above and beyond a general indicator of cognitive
functioning.
Using blockwise regression analyses entering (b) mem-
ory functioning in the first block of the regression model,
Behavioural Neurology 5
Table 3: Linear regressions analyses (forward selection) predicting variances in pain responsiveness (NFR threshold and facial responses).






Intellectual abilities/executive function .411 .169 <.001 −.393 .154 .001
Excluded
orientation .060 .663 .026 .852
Memory .220 .129 −.058 .697
Apraxia and aphasia .195 .177 −.137 .355
Information processing speed −.112 .409 .088 .521
Table 4: Linear regressions analyses (blockwise) showing the predictive power of “intellectual abilities/executive function” to explain variance
in pain responsiveness (NFR threshold and facial responses) after controlling for (a) the general cognitive functioning and (b) memory
functioning.
Step Predictor Criterion: NRF threshold Criterion: facial response
𝛽 𝑡 Total 𝑟2 Δ𝑟2 𝑝 (Δ𝑟2) 𝛽 𝑡 Total 𝑟2 Δ𝑟2 𝑝 (Δ𝑟2)
(a)
1 MMSE .356 3.136 .126 .126 .003 −.279 −2.378 .078 .078 .020
2 Intellectual abilities/executive function .315 2.081 .179 .053 .041 −.377 −2.444 .154 .077 .017
(b)
1 Memory .394 3.533 .155 .155 .001 −.286 −2.443 .082 .082 .017
2 Intellectual abilities/executive function .278 1.971 .204 .049 .046 −.355 −2.409 .156 .074 .019
we also found a significant increase in explained variance
after entering “intellectual abilities/executive function” in
the second block. This was true for both types of pain
responses (NFR thresholds and facial responses). As can
be seen in Table 4, “intellectual abilities/executive function”
added approximately 5–7% of explained variance to the
explanatory power of memory functioning. Thus, “intellec-
tual abilities/executive function” helps explain variances in
pain responses even above and beyond those explained by
memory functioning.
4. Discussion
There were two major findings of the present study. (i)
Increasing levels of cognitive decline appeared to be associ-
ated with enhanced pain responses. This interpretation can
be based on both indicators of pain processing studied, facial
expression of pain and NFR-reflex, which are independent
from introspection and self-report, making them especially
robust for the use in patients with dementia. (ii) Intellectual
abilities/executive functions contributed overproportionally
to the explanation of the changes in pain responses.
The first finding adds to the frequent observations that
dementia (mainly Alzheimer’s disease) is associated with
changes in pain processing [2]. There is, however, some
controversy with regard to the direction of change. Whereas
in most of the studies patients with dementia appeared to be
more sensitive to pain [8, 9, 23], some other studies showed
no [24, 25] or opposite effects [26]. Part of the controversy can
be resolved by considering themethods applied to assess pain
because the behavioral and physiological indicators favor
the assumption of an enhanced pain processing [8, 9, 23],
while the parameters based on subjective report show no
differences [24, 25] or even dampened pain processing [26].
The more interesting finding is the second one; namely,
the changes in pain processing were best explained by the
executive function of the patients. Even when the general
cognitive status and memory dysfunction in the patients
with MCI and dementia were controlled for, executive
functions explained extra variance in pain responses. The
testing of executive functions contained items of abstract
thinking (explaining the meaning of idiomatic expressions
and semantic differences) and judgement (describing pic-
tures representing actions (Luria thematic pictures) and
plausibility judgements) [10]. It is widely acknowledged that
abstract thinking and judgement are both key components
of executive functioning [27, 28]. The worse these capacities
of abstract thinking and judgment were, the stronger the
increase in pain processing was. This fits well with the idea
that the dorsolateral prefrontal cortex (DLPC) is responsible
for both these higher cortical functions of cognition [29]
and the cortical phase of the descending inhibitory control
system of pain [30]. Thus, worsening of this type of executive
functions and the loss of pain inhibitory potency might well
run in parallel. The observation that pain activates again and
again the DLPC in patients with Alzheimer’s disease might
accordingly be seen as unsuccessful attempts to start the
cortical phase of descending pain inhibition because of a loss
of DLPC functionality [31]. We have to acknowledge that no
study so far has actually looked at brain activation patterns
accompanying the abstract thinking and judgement tasks of
the SIDAM, and thus we cannot be sure that these items
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were indeed linked to DLPFC dysfunction or to dysfunctions
in other frontal areas. Therefore, the interpretation that
DLPFC dysfunction underlies both the decline in executive
functioning and the decline in pain inhibition is only very
speculative.
A study by Scherder et al. [32] seems to corroborate
the present finding of a close relation between pain pro-
cessing and executive functioning by showing a significant
association of executive functions (Digit Span Backward,
Category Fluency, and Knox’s Cube Imitation Test) and
the intensity of arthrosis or arthritis pain in patients with
Alzheimer’s disease. However, the direction of the correlation
was reversed. The better the executive functions were, the
more the patients suffered from pain. The close but intricate
relationship between disruption of prefrontal areas and pain
processing is also indicated by Fletcher et al. [33] who
assumed on one hand a higher pain prevalence in patients
with frontal lobe damage but on the other hand assumed
blunted responsiveness to pain in behavioral variant FTD and
semantic dementia. This unpredictable closeness between
prefrontal functions and pain is also nicely described byDenk
et al. [30] who showed clearly that the whole prefrontal cortex
appeared to be more or less engaged in certain stages of pain
processing. (inhibition, reward, and perception). In line with
this, Oosterman et al. [34] could show that executive function
predicted pain sensitivity to a cold pressor test, with higher
executive functioning being associated with less sensitivity to
pain (the same direction that we found). In consequence, our
finding that the disruption of executive functions in patients
withmild-to-moderate degrees of dementia-related cognitive
impairment is related to a deterioration of pain inhibition
and, in consequence, to enhanced pain responses is very
plausible. However, it may well be that the testing of other
executive functions with implementation in other areas of the
prefrontal cortex may change the picture substantially.
Our study has methodological strengths and weaknesses.
The tests of pain responses were largely independent from
self-report and were robust for the use with patients with
dementia as shown in other studies [9]. The SIDAM is a
comprehensive test battery for cognitive functioning tailored
to the testing capability of patients with dementia. However, it
includes only a few items for each cognitive domain, and how
strongly the items assessing “abstract thinking” and “judge-
ment” correlate with other tests of executive functioning has
not been tested, whichmay lower its reliability and its validity,
respectively.
5. Conclusions
The cognitive decline in patients with dementia-related cog-
nitive impairment appeared to be paralleled by an enhance-
ment of pain responses.This close relation between cognitive
functions and pain parameters gives further support to
the idea that pain assessment in patients with dementia
should be regularly completed by tests of cognitive functions.
Memory functions proved to be important for this relation
but did not exceed other cognitive domains in this respect.
In contrast, the disruption of executive functioning appeared
to be especially predictive for enhanced pain responses in
patients with dementia-related cognitive decline. Given the
present results, we suggest that pain diagnostics in patients
with dementia should be accompanied by an assessment of
executive functions.
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